Sherlock Biosciences announced today that it appointed Julie Garlikov as its first chief commercial officer. In her role, Garlikov will serve as a member of the point-of-need molecular diagnostic developer’s executive team and will be responsible for driving commercial strategy for the decentralized diagnostics platform. Garlikov will report to Bryan Dechairo, who serves as president […]
Sherlock Biosciences
Sherlock Biosciences raises $80M Series B for at-home diagnostics
Sherlock Biosciences announced today that it raised $80 million in a Series B financing round to support its next-generation diagnostics. Novalis LifeSciences led the round, which included new investors Illumina Ventures, Albany Capital and Catalio Capital Management, among others. The new investors joined Northpond Ventures, Good Ventures and other existing investors, bringing Sherlock’s total funding […]
Sherlock Biosciences names new CEO
Sherlock Biosciences announced today it appointed Bryan Dechairo as its president and CEO and he will join the company’s board. Dechairo will succeed co-founder Rahul Dhanda, who will continue to serve as a board member until the end of 2021, after which he will assume the role of strategic adviser in 2022. He joins Cambridge, […]
20 medical device startups you need to know
The medtech industry isn’t immune from COVID-19 troubles, but exciting innovation continues. These 20 medical device startups have grabbed our attention. Tom Salemi, DeviceTalks Editorial Director and Sean Whooley, Assistant Editor A number of medical device startups continue to make waves across the space, with new technologies and eye-watering fundraising rounds highlighting some exciting prospects. […]
Sherlock Biosciences announces manufacturing partnership for CRISPR-based COVID-19 test
Sherlock Biosciences announced today that it will collaborate with Integrated DNA Technologies (IDT) to enable large-scale manufacturing of the Sherlock CRISPR SARS-CoV-2 kit for COVID-19 detection. Officials at Cambridge, Mass.–based Sherlock Biosciences think the company’s CRISPR-based diagnostic test, which recently received an FDA emergency use authorization, will increase testing capacity and decreasing time to result […]
